Drug recall · August 26, 2020
Pain Relief Maximum Strength recall
Why: Failed Stability Specifications: Out-of-Specification (OOS) results for the Aspirin related compound Salicylic Acid was observed.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Pain Relief Maximum Strength (Acetaminophen 250 mg/aspirin 250 mg/Caffeine 65 mg) tablets, 2-tablets per packet, Manufactured for Select Corporation, Carrollton, TX 75007
- Lots / codes
Lot #: AK8745, Exp. Date 08/20; AK9751, Exp. Date 08/2021; AK9552, Exp. Date 04/2022
- Quantity
- 4,666,355 packets
- Company
- Ultra Seal Corporation, New Paltz, NY
- Distribution
- Product was shipped to two distributors in IL and TX who may have further repackaged and distributed the product.
- Initiated
- August 3, 2020 · Voluntary: Firm initiated
- Classified
- August 20, 2020
- Reported
- August 26, 2020
- Ended
- March 16, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Aspirin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.